+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Deep Brain Stimulation in Parkinson's Disease Market by Product (Dual Channel, Single Channel), End-User (Ambulatory Surgical Centers, Hospitals, Neurology Clinics) - Forecast 2024-2030

  • PDF Icon

    Report

  • 189 Pages
  • January 2024
  • Region: Global
  • 360iResearch™
  • ID: 5532737
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Deep Brain Stimulation in Parkinson’s Disease Market size was estimated at USD 1.07 billion in 2023, USD 1.23 billion in 2024, and is expected to grow at a CAGR of 15.40% to reach USD 2.93 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Deep Brain Stimulation in Parkinson’s Disease Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Deep Brain Stimulation in Parkinson’s Disease Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Deep Brain Stimulation in Parkinson’s Disease Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Beijing Pins Medical Co.,Ltd., Boston Scientific Corporation, Functional Neuromodulation Ltd., General Electric Co., Medtronic PLC, MicroTransponder Inc., Neuronetics Inc., NeuroPace Inc., NeuroSigma, Inc., Nexstim Oy, Renishaw PLC, Siemens AG, St. Jude Medical, Inc., and Synapse Biomedical Inc.

Market Segmentation & Coverage

This research report categorizes the Deep Brain Stimulation in Parkinson’s Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Dual Channel
    • Single Channel
  • End-User
    • Ambulatory Surgical Centers
    • Hospitals
    • Neurology Clinics
    • Research Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Deep Brain Stimulation in Parkinson’s Disease Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Deep Brain Stimulation in Parkinson’s Disease Market?
  3. What are the technology trends and regulatory frameworks in the Deep Brain Stimulation in Parkinson’s Disease Market?
  4. What is the market share of the leading vendors in the Deep Brain Stimulation in Parkinson’s Disease Market?
  5. Which modes and strategic moves are suitable for entering the Deep Brain Stimulation in Parkinson’s Disease Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Frequently Asked Questions about the Global Deep Brain Stimulation in Parkinson’s Disease Market

What is the estimated value of the Global Deep Brain Stimulation in Parkinson’s Disease Market?

The Global Deep Brain Stimulation in Parkinson’s Disease Market was estimated to be valued at $1.23 Billion in 2024.

What is the growth rate of the Global Deep Brain Stimulation in Parkinson’s Disease Market?

The growth rate of the Global Deep Brain Stimulation in Parkinson’s Disease Market is 15.4%, with an estimated value of $2.93 Billion by 2030.

What is the forecasted size of the Global Deep Brain Stimulation in Parkinson’s Disease Market?

The Global Deep Brain Stimulation in Parkinson’s Disease Market is estimated to be worth $2.93 Billion by 2030.

Who are the key companies in the Global Deep Brain Stimulation in Parkinson’s Disease Market?

Key companies in the Global Deep Brain Stimulation in Parkinson’s Disease Market include Abbott Laboratories, Aleva Neurotherapeutics SA, Beijing Pins Medical Co.,Ltd., Boston Scientific Corporation, Functional Neuromodulation Ltd., General Electric Co., Medtronic PLC, MicroTransponder Inc., Neuronetics Inc. and NeuroPace Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Deep Brain Stimulation in Parkinson’s Disease Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of neurological diseases
5.1.1.2. Rapidly aging population, leading to risk and high prevalence of neurological disorders
5.1.1.3. Rising popularity of minimally invasive procedures
5.1.2. Restraints
5.1.2.1. Complex regulatory framework
5.1.3. Opportunities
5.1.3.1. Increasing technological advancement in devices
5.1.3.2. Surge in neurological R&D
5.1.4. Challenges
5.1.4.1. Complications of deep brain stimulation surgery
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Deep Brain Stimulation in Parkinson’s Disease Market, by Product
6.1. Introduction
6.2. Dual Channel
6.3. Single Channel
7. Deep Brain Stimulation in Parkinson’s Disease Market, by End-User
7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Hospitals
7.4. Neurology Clinics
7.5. Research Centers
8. Americas Deep Brain Stimulation in Parkinson’s Disease Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Aleva Neurotherapeutics SA
12.1.3. Beijing Pins Medical Co.,Ltd.
12.1.4. Boston Scientific Corporation
12.1.5. Functional Neuromodulation Ltd.
12.1.6. General Electric Co.
12.1.7. Medtronic PLC
12.1.8. MicroTransponder Inc.
12.1.9. Neuronetics Inc.
12.1.10. NeuroPace Inc.
12.1.11. NeuroSigma, Inc.
12.1.12. Nexstim Oy
12.1.13. Renishaw PLC
12.1.14. Siemens AG
12.1.15. St. Jude Medical, Inc.
12.1.16. Synapse Biomedical Inc.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET RESEARCH PROCESS
FIGURE 2. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2023 VS 2030
FIGURE 3. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET DYNAMICS
FIGURE 7. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Beijing Pins Medical Co.,Ltd.
  • Boston Scientific Corporation
  • Functional Neuromodulation Ltd.
  • General Electric Co.
  • Medtronic PLC
  • MicroTransponder Inc.
  • Neuronetics Inc.
  • NeuroPace Inc.
  • NeuroSigma, Inc.
  • Nexstim Oy
  • Renishaw PLC
  • Siemens AG
  • St. Jude Medical, Inc.
  • Synapse Biomedical Inc.

Methodology

Loading
LOADING...